Katrina J. Church - Mar 15, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & Chief Compliance Officer
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: Mar 15, 2024
Transactions value $: -$6,645
Form type: 4
Date filed: 3/20/2024, 06:41 PM
Previous filing: Mar 18, 2024
Next filing: Apr 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Sale	-$6.64K	-1.22K	-7.96%	$5.46	14.1K	Mar 15, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 14, 2024 pursuant to a standing 10b5-1 instruction.
F2	The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple stockholders in multiple transactions at prices ranging from $5.13 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.

Content

Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 14, 2024 pursuant to a standing 10b5-1 instruction.

The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple stockholders in multiple transactions at prices ranging from $5.13 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.